I hate how almost every long trying to turn this into positive. I'm long for over 2 years and for sure not happy with offering and price asked. They talk all about money lasting into 2016 and do offering? #$%$?
Also why the investors didn't buy shares by regular way, on the market. Not even GS when they buying big chunks for portfolio making deals like this. They just trade in dark pool. I'm kinda disappointed with dilution. Honestly
All this money have to last them into 2017. What is #$%$ me off is the IR presentation where they just talking like there will be no offering at least till 2016. Otherwise I don't see any point for them to pushing all the time for how long the money last
Same here. The first patient was the best case scenario. This one is the worst. I think that is perfect.
All I can say
If he will, you never see this stock to trade under $20 again. It would be "miracle", revolution, breakthrough. Goal is safety.
You must be some idiot to talk like this. Most of the long term holders expecting safety being proven. Not him to walk in 30 days with his scaffold without stem cells.
The cell therapy makes sense when is done together with scaffold. That is what I think. Also I don't think the chronic SCI is at the top of the list now.
Everyone is different. Just because you have 50% of your portfolio in OTC stocks doesn't mean you are nuts. You have to do DD and secure the not much secured with ones which are safe in relative way. High risk is can bring high reward. Of course you have to risk money you don't care for if you lose. Not advising anybody with 20k in savings to put 50% or more into OTC biotech.
i see no. 3 as most likely outcome. I think this is just a one more step to big thing which is scaffold plus cells. The polish guy story shows the cells to be effective...there is just something missing and that is the scaffold.
it took 2 years to get him where he is now. Will he be able to walk ever without help? i don't know. He have some sensation in bladder, that is the good news. Combined with scaffold and timely surgery this will be revolution. The only thing now for NVIV is to pick the type of stem cells which will provide the best results. That maybe hard.
100% big offering before start of trials. They need to lift up price so there is a video and some more will come.
CUR is pump and dump pos. BTW I'm sure this is not just CUR promotion right? Ohhh...it is. Why would you otherwise write non sense as this.How they missing boat? Why would you bring up stock which have no connection to NVIV. Why would you tell a story? Gimme a break.
Forget what? How to do spine surgery? They are all spine surgeons. That would mean every each of them after 2 moths of vacation would have to go back to school according to you.
The other will come just to beg for licensing. With that they can easily become 2B MC just on Rexista alone. The current price is a gift.